Patents for C12P 21 - Preparation of peptides or proteins (112,499)
04/1986
04/02/1986EP0175852A2 Method for producing useful substances using genetically engineered viral DNA
04/01/1986US4579827 Monoclonal antibodies to human gastrointestinal cancers and hybridoma method of production of the monoclonal antibodies
04/01/1986US4579820 Process for enzymatic replacement of the B-30 amino acid in insulins
04/01/1986CA1202587A1 Semi-synthetic preparation of human insulin
04/01/1986CA1202585A1 Process for preparing substance having carcinostatic and immunostimulating activity
04/01/1986CA1202581A1 Adaptor molecules for dna and their application to synthesis of gene-derived products
04/01/1986CA1202566A1 Separation of plasma proteins from cell culture systems
03/1986
03/27/1986WO1986001834A1 Retroviral polypeptides associated with human cellular transformation
03/27/1986WO1986001827A1 Cloned dna sequences, hybridizable with genomic rna of lymphadenopathy-associated virus (lav)
03/27/1986WO1986001808A1 Monoclonal antibodies and their use
03/27/1986WO1986001807A1 Monoclonal antibodies and their use
03/27/1986WO1986001806A1 Monoclonal antibodies and their use
03/27/1986WO1986001805A1 Monoclonal antibodies and their use
03/27/1986WO1986001804A1 Monoclonal antibodies and their use
03/27/1986WO1986001802A1 Antigens of plasmodium falciparum
03/27/1986WO1986001723A1 Method of rectification of human leukocytic interferon
03/27/1986WO1986001722A1 Method of obtaining human leukocytic interferon
03/27/1986WO1986001718A1 METHOD FOR OBTAINING THE COMPLEX FVIII/vWF OF THERAPEUTIC USE AND PRODUCTS RESULTING THEREFROM
03/26/1986EP0175283A1 Recombinant dna and use thereof
03/26/1986EP0175261A2 Hybrid particle immunogens
03/25/1986US4578458 Mucoid exopolysaccharide vaccine against Pseudomonas aeruginosa
03/25/1986US4578335 Interleukin 2 receptor
03/25/1986CA1202261A1 A47934 antibiotic and its production
03/25/1986CA1202257A1 Method for expressing a gene
03/25/1986CA1202256A2 Microbial expression of quasi-synthetic genes
03/19/1986EP0174874A2 Hybrid cell line producing monoclonal antibody cytolytic to trichomonas vaginalis
03/19/1986EP0174785A1 A positive retroregulatory element, plasmid and cells comprising said element and their production, a method of enhancing gene expression using said element and a method of enhancing RNA half life using said element
03/19/1986EP0174759A1 Multispecific immunogenic proteins
03/19/1986EP0174608A1 Beta-actin gene and regulatory elements, preparation and use
03/19/1986EP0174585A2 Promoters and the use thereof in the expression of unfused procaryotic or eucaryotic proteins in yeast
03/19/1986EP0174534A1 Immunoassay for breast cancer employing monoclonal antibodies
03/18/1986EP0162078A4 Method for isolating a protein from a mixture containing said protein and a conformation specific antibody useful therein.
03/18/1986CA1201988A1 Cancer cell-combatting lymphocytes, process for the production thereof and anticancer agents containing said lymphocytes
03/13/1986WO1986001539A1 Method of producing monoclonal anti-idiotypic antibodies
03/13/1986WO1986001536A1 Bacillus thuringiensis crystal protein gene toxin segment
03/13/1986WO1986001533A1 Production of chimeric antibodies
03/13/1986WO1986001532A1 Polypeptide and polypeptide composition
03/13/1986WO1986001531A1 Detachment of anchorage-dependent cells from microcarriers
03/13/1986WO1986001517A1 Herpes virus specific immunological materials and methods
03/13/1986WO1986001515A1 Expression of human connective tissue activator and related peptides
03/13/1986WO1986001411A1 Anti-urokinase monoclonal antibody; its production and use
03/13/1986WO1986001410A1 Antibody-metal ion complexes
03/13/1986WO1986001407A1 Monoclonal antibodies against metal chelates
03/12/1986EP0174228A1 Process for diagnosing human Papilloma virus infections, monoclonal antibodies specific for a type of human Papilloma virus, and hybridomalines secreting them
03/12/1986EP0174204A2 Gram-negative bacterial endotoxin blocking monoclonal antibodies and cells producing the same and formulations containing the same, and the production of all thereof
03/12/1986EP0174143A1 Novel, distinct family of human leukocyte interferons, compositions containing them, methods for their production, and DNA and transfected hosts therefor
03/12/1986EP0173973A2 Method for the determination of thyroid-stimulating hormone
03/12/1986EP0173924A2 Mechanical process for dislodging bacterial cells for the isolation of peptides prepared by recombinant techniques
03/12/1986EP0173887A1 Novel interferon alphas
03/11/1986US4575489 Streptomyces albulus subsp. ochragerus subsp. nov. culture for making peptide
03/11/1986US4575484 Diagnosis of tuberculosis
03/11/1986CA1201668A1 Synthetic dna and method therefor
03/11/1986CA1201667A1 Diagnostic reagent and method
03/05/1986EP0173668A1 Recombinant saccharomyces
03/05/1986EP0173663A2 The use of a specific tumor associated antigen, sialosyllactotetraose, in diagnostic or therapeutic procedures related to cancer deseases
03/05/1986EP0173629A1 Antibody-metal ion complexes
03/05/1986EP0173619A1 Method for the preparation of a strain, particularly from yeast, transformed by an expression vector, that can be propagated in a complete medium, without selection pressure, and strain thus obtained
03/05/1986EP0173552A1 Recombinant DNA compounds and the expression of polypeptides such as tPA
03/05/1986EP0173500A1 Methods of concentrating ligands and active membranes used therefor
03/05/1986EP0173494A2 Chimeric receptors by DNA splicing and expression
03/05/1986EP0173378A2 Process for preparing a polypeptide by culturing a transformed microorganism, a transformed microorganism suitable therefor and DNA sequences suitable for preparing such microorganism
03/05/1986EP0173341A1 Method for the determination of hormones
03/05/1986EP0173327A2 Bialaphos producing gene
03/05/1986EP0173280A1 Plasmids containing lambda Pl promoter, and engineered restriction site for convenient replacement of ribosomal binding site, hosts containing the plasmids and related methods
03/05/1986EP0173254A1 DNA sequences of the EBV genome, recombinant DNA molecules, processes for producing EBV-related antigens, diagnostic compositions and pharmaceutical compositions containing said antigens
03/05/1986EP0173215A2 Method for recovering purified growth hormones from genetically engineered microorganisms
03/05/1986EP0173149A1 Synthetic regulation region
03/04/1986US4574116 Methods and cell lines for immortalization and monoclonal antibody production by antigen-stimulated B-lymphocytes
03/04/1986CA1201402A1 Process for preparation of aspartylphenylalanine alkyl esters
03/04/1986CA1201396A1 Process for the preparation of permanent animal and human cell lines and their use
02/1986
02/27/1986WO1986001229A1 Method of removing n-terminal amino acid residues from eucaryotic polypetide analogs and polypeptides produced thereby
02/27/1986WO1986001228A1 Immunogenic conjugates of e. coli lt-b enterotoxin subunit and capsular polymers
02/27/1986WO1986001224A1 Process for the preparation of a strain, particularly of yeast, transformed by an expression vector, and which may be cultivated on a complete medium without selection pressure, and strain thus obtained
02/27/1986WO1986001222A1 New hybride cells secreting anti-idiotypic antibodies, new monoclonal antibodies secreted by said hybride cells, preparation and application thereof
02/27/1986WO1986001212A1 Minactivin
02/27/1986WO1986001080A1 Processes for recovery of products from waxy barley
02/26/1986EP0172471A2 Herpes virus specific immunological materials and methods
02/26/1986EP0172361A2 Cloned cardionatrin cDNA, cleaved cardionatrin cDNA and cardionatrin precursors, their preparation, corresponding plasmids and microorganisms comprising said plasmid
02/25/1986US4572896 Monoclonal antibodies to herpes simplex virus type I polypeptides
02/25/1986US4572894 Using aminoacyl-trna synthetase as condensing agent
02/25/1986CA1201116A1 High potency, mycelial-free avoparcin alkyl sulfate complex, and method for the preparation thereof
02/25/1986CA1201079A1 Method of manufacturing biologically active substances
02/25/1986CA1201074A1 Plasmid for producing human proinsulin
02/19/1986EP0172107A1 Immunogenic conjugates of E. coli LT-B enterotoxin subunit and capsular polymers
02/19/1986EP0171908A2 Hepatitis B virus surface antigen and production thereof
02/19/1986EP0171887A2 Anti-diabetic compounds
02/19/1986EP0171886A2 Anti-diabetic compounds
02/19/1986EP0171496A2 Process for the production of a chimera monoclonal antibody
02/18/1986CA1200777A1 A-21978c cyclic peptide derivatives and their production
02/18/1986CA1200773A1 Expression linkers
02/13/1986WO1986000928A1 Cell treatment
02/13/1986WO1986000927A1 Antibody production
02/13/1986WO1986000923A1 Yeast cloning vehicles
02/13/1986WO1986000911A1 Protective peptide antigen corresponding to plasmodium falciparum circumsporozoite protein
02/13/1986WO1986000909A1 Monoclonal antibody directed to human ganglioside gd2
02/12/1986EP0171260A2 Hepatitis B vaccine
02/12/1986EP0171147A2 Anti-diabetic compounds
02/12/1986EP0171142A1 Methods for producing proteins and transformed cells, and DNA constructs for correcting host cell deficiencies and their preparation and use
02/12/1986EP0171083A2 Monoclonal antibody, process for preparing same, reagent for detecting cancer antigen containing the monoclonal antibody and process for preparing same
02/12/1986EP0171024A1 Genetic engineering process for the production of hirudins, and agents for carrying out said process